RecruitingPhase 2NCT05607719

Inhaled Corticosteroids (ICS) on Pulmonary Endothelial Function in COPD

The Effect of Inhaled Corticosteroids (ICS) Adjunct Therapy on Pulmonary Vascular Endothelial Function in Chronic Obstructive Pulmonary Disease (COPD): Comparison of Two Standard Treatments (NCT05607719


Sponsor

University of Miami

Enrollment

30 participants

Start Date

Apr 11, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The study objective is to determine whether an ICS added for 4 weeks to a baseline treatment with a Long-Acting Beta-adrenergic Agonist (LABA) and Long-Acting Muscarinic Antagonist (LAMA) combination improves pulmonary vascular endothelial function as assessed by the vasodilator response to inhaled albuterol (endothelium-dependent vasodilation) in stable COPD patients treated with a LABA/LAMA without an ICS for at least one month.


Eligibility

Min Age: 40 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study examines whether adding inhaled corticosteroids (anti-inflammatory inhalers) to standard COPD treatment affects blood vessel function in the lungs of people with moderate COPD. **You may be eligible if...** - You have been diagnosed with COPD by a physician - You have a smoking history of more than 10 pack-years - Your lung function tests show moderate COPD (FEV1 between 50–80% of predicted, FEV1/FVC ratio below 0.7) - You are between 40 and 80 years old - You are already taking a LAMA/LABA (long-acting bronchodilator) combination for at least a month **You may NOT be eligible if...** - You are a woman of childbearing age not using contraception - You are pregnant or breastfeeding - You had a respiratory infection in the past 4 weeks - You recently received a COVID-19 vaccination (within a certain window — check with your doctor) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGBevespi

Two puffs twice a day

DRUGBretzri

Two puffs twice a day


Locations(1)

University of Miami

Miami, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05607719


Related Trials